The relation between dietary calcium, calcium, and vitamin D supplements and the risk of fractures of the hip (n = 332), ankle (n = 210), proximal humerus (n = 241), wrist (n = 467), and vertebrae (n = 389) was investigated in a cohort study involving 9,704 US white women aged 65 years or older. Baseline assessments took place in 1986-1988 in four US metropolitan areas. Dietary calcium intake was assessed at baseline with a validated food frequency questionnaire. Data on new nonvertebral fractures were collected every 4 months during a mean of 6.6 years of follow-up; identification of new vertebral fractures was based on comparison of baseline and follow-up radiographs of the spine done_a mean of 3.7 years apart. Results were adjusted for numerous potential confounders, including weight, physical activity, estrogen use, protein intake, and history of falls, osteoporosis, and fractures. There were no important associations between dietary calcium intake and . the risk of any of the fractures studied. Current use of calcium supplements was associated with increased risk of hip (relative risk = 1.5, 95% confidence interval 1.1-2.0) and vertebral (relative risk = 1.4, 95% confidence interval 1.1-1.9) fractures; current use of Turns antacid tablets was associated with increased risk of fractures of the proximal humerus (relative risk = 1.7, 95% confidence interval 1.3-2.4). There was no evidence of a protective effect of vitamin D supplements. Although a true adverse effect of calcium supplements on fracture risk cannot be ruled out, it is more likely that our findings are due to inadequately controlled confounding by indications for use of supplements. In conclusion, this study did not find a substantial beneficial effect of calcium on fracture risk. Am J Epidemiol 1997;145:926-34.
Although randomized trials have clearly demonstrated that calcium supplements reduce the rate of bone loss in postmenopausal women (1-6), the efficacy of calcium for fracture prevention remains unclear. Observational epidemiologic studies of dietary calcium and fractures are inconsistent. There have been at least 14 studies of hip fracture and dietary calcium (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , and only three of these found a clearly protective effect. On the other hand, two small randomized trials have found a reduced rate of radiographic vertebral fractures among subjects given calcium supplements (21, 22) , and another small study found a nonsignificant reduction in risk of symptomatic vertebral and nonvertebral fractures (23) . A large French trial found that a combination of calcium and vitamin D supplements halved the hip fracture rate among women living in nursing homes (24) .
To assess the relation between calcium intake and the risk of fractures, we analyzed data from the Study of Osteoporotic Fractures, a cohort study of 9,704 white women aged 65 years and over who have been followed up for more than 6 years. We investigated dietary calcium, calcium supplements, vitamin D supplements, and the risk of fractures at a number of sites: hip, ankle, proximal humerus, wrist, and vertebrae.
MATERIALS AND METHODS Subjects
From 1986 to 1988, women aged 65 years or more were recruited from Portland, Oregon; Minneapolis, Minnesota; Baltimore, Maryland; and the Monongahela Valley, Pennsylvania. Recruitment involved mailings to women on population-based lists (voter registration, driver's license, and health maintenance organization lists). We excluded black women, women who were unable to walk without assistance, and women who had had bilateral hip replacements.
Calcium intake
Dietary calcium was estimated with a validated food frequency questionnaire, developed from the Second National Health and Nutrition Examination Survey (25) . Subjects were asked how often in the last year they usually ate each of 20 foods. Food models were used to assist subjects to rate their usual portion size for each food as small, medium, or large. Inclusion of foods on the questionnaire was based on their contribution to total calcium and protein intake in US adults. The foods accounted for about 80 percent of calcium intake, and the correlation between calcium intake in elderly women assessed with the questionnaire and 7-day food records was 0.76 (26) . The questionnaire also inquired about the frequency of drinking glasses of milk during teenage years, between the ages of 18 and 50 years, since the age of 50 years, and during pregnancy and breastfeeding.
Women were asked to bring all medications to the baseline clinic visit. For women who had ever used a calcium supplement, we collected information on the name(s) and dose(s) of currently used calcium supplements and the calcium supplement they had used for the longest time. We also asked about the age at which calcium supplements had first been used and whether there was any period when they had not been used. Similar data were collected for Turns antacid tablets, a brand name medication containing calcium which is sold as an antacid (SmithKline Beecham, Philadelphia, Pennsylvania). Multivitamin supplements containing vitamin D were included in the vitamin D supplement category. We obtained data on the duration of use of vitamin D supplements but not on dose.
Other measurements
Baseline data on a wide range of possible risk factors for osteoporotic fractures were collected by questionnaire and examination in outpatient clinics (27, 28) . Among the factors assessed by questionnaire were alcohol use, smoking, caffeine intake, parental history of fractures, falls during the past year, self-rated health, walking for exercise, and difficulties in activities of daily living. A modified Paffenbarger questionnaire was used to assess recreational physical activity in the past year, expressed in kilocalories per week (29) . We asked about physician-diagnosed fractures since the age of 50, osteoporosis, spine fracture, hyperthyroidism, Parkinson's disease, and stroke. Women were also asked if they had ever taken estrogen, thiazide diuretics, thyroid hormones, or psychotropic medications. The food frequency questionnaire described above was also used to obtain an approximate estimate of dietary protein intake.
Among the factors assessed by examination were height, weight, the ability to stand up from a chair without using arms, the time to complete a measured course walking normally and with feet in tandem, depth perception using a Howard-Dohlman device (Lafayette Instruments, Lafayette, Indiana), and contrast sensitivity using a Vistech VCTS 6500 wall chart (Vistech Company, Dayton, Ohio) (28, 30, 31) .
Ascertainment of incident fractures
We contacted women by postcard or telephone every 4 months and asked whether they had had a fracture. Over 99 percent of these contacts were completed. Radiology reports were reviewed (32) , and only radiologically confirmed fractures are included in this paper. In addition, hip fractures were confirmed and classified by type (trochanteric or femoral neck) after review of preoperative radiographs by the study radiologist (H. K. Genant, University of California, San Francisco, California). Wrist fractures include all fractures of the distal radius or ulna, and humeral fractures include only fractures of the proximal humerus. Fractures that resulted from major trauma, such as motor vehicle accidents, were excluded (5 percent of all fractures).
Vertebral fractures were assessed by morphometry (quantitative assessment of vertebral heights by digitization), with comparison of baseline and follow-up lateral thoracic and lumbar spine films obtained a mean of 3.7 years apart. An incident vertebral fracture was defined as at least a 20 percent and 4-mm decrease in the anterior, middle, or posterior height of the vertebral body (33) . The study radiologist reviewed discrepancies between morphometry and a technician's qualitative assessment of radiographs; the radiologist also visually confirmed all incident vertebral fractures (34, 35) . Follow-up radiographs were not done for 2,466 women. The baseline prevalence of vertebral deformity was very similar in women with (20 percent) and without (21 percent) follow-up radiographs.
Statistical analysis
We used proportional hazards models to assess the relation between calcium intake and the various types of nonvertebral fractures. Logistic regression was used to analyze the vertebral fracture data, as these fractures were identified by a planned radiographic survey. For simplicity, we use the term relative risk to describe 928 dimming et al.
both hazard ratios (from proportional hazard models) and odds ratios (from logistic regression models).
Follow-up duration in proportional hazards models was the time from baseline interview/examination in 1986-1988 to first relevant fracture, death, or end of follow-up (March 1, 1995), whichever came first. For hip fracture analyses, we excluded women with a history of hip fracture prior to enrolment in the study. This approach was not used for other types of fracture, because their self-report is less accurate (32) . Unless otherwise stated, analyses involving new vertebral fractures included women with and without vertebral fractures on baseline radiographs.
Selection of potential confounders for inclusion in multiple factor models was based on 1) previously published research on risk factors for fractures (mostly research on hip fractures) and 2) the distribution of these risk factors across categories of dietary calcium and supplement use among study participants.
Dietary calcium intake is a continuous variable; however, we also categorized dietary calcium on the basis of current beliefs about optimal calcium intake and the availability of sufficient numbers of subjects and fractures in each category: less than 400 mg/day, 400-799 mg/day, 800-1,199 mg/day, and 1,200 or more mg/day. We tested for trends in relative risks across categories by modeling the median calcium intakes for each category as a single continuous variable.
Analyses for calcium supplements, Turns antacid tablets, and vitamin D supplements compared current users with never users and exusers with never users. Current total daily calcium intake was estimated by summing the milligrams of calcium consumed in the diet, in calcium supplements, and in Turns antacid tablets (each tablet contains about 200 mg of calcium).
We assessed the interaction between calcium intake and the history of fractures or osteoporosis using the Breslow-Day test for heterogeneity in stratified analyses and by including interaction terms in multiple factor models. We used similar techniques to assess the interaction between calcium intake and physical activity, use of estrogen replacement therapy, and family history of fractures.
All p values are two sided; a p value < 0.05 was used to define statistically significant associations. All analyses were done with SAS version 6.08 software (SAS Institute, Inc., Cary, North Carolina) using an IBM-compatible personal computer.
Literature review
Studies on calcium intake and fractures were identified by reviewing all publications known to the authors that might contain relevant data. Reference lists of these articles were also reviewed, and possibly relevant articles were retrieved. A few additional articles were identified by conducting a computerized Medline search for the period from January 1966 to December 1995 using the text words "fracture" and "calcium." To be eligible for our review, studies had to have fractures (or a particular type of fracture) as the outcome.
RESULTS
During a mean of 6.6 years of follow-up of 9,704 subjects, there were 332 hip fractures, 210 ankle fractures, 241 proximal humeral fractures, and 467 wrist fractures. The total number of nonvertebral fractures was 1,950. There were 389 new vertebral fractures among the 7,238 women who had both baseline and follow-up vertebral radiographs.
The baseline distribution of dietary calcium intake and the use of calcium supplements, Turns antacid tablets, and vitamin D supplements among women in our study are shown in table 1. The mean daily dietary calcium intake was 714 mg (standard deviation, 425 mg). The mean dietary calcium intake varied by clinic from a low of 627 mg in Pittsburgh to a high of 772 mg in Minneapolis. Table 2 shows risk factors for fractures that were associated with calcium intake in our data. Compared with women having lower dietary calcium intakes, those having higher intakes were more likely to have histories of osteoporosis and fractures, to have fallen in the past year, and to use estrogen replacement therapy; they were less likely to use thiazide diuretics. These women also tended to have better contrast sensitivity scores, to eat more protein, to consume less caffeine, and to be more physically active. Dietary calcium intake was not associated with the use of calcium or Turns antacid tablets, but vitamin D use was more common among women with higher dietary calcium intakes.
The major differences between users and nonusers of calcium supplements were that users were more likely to have histories of osteoporosis and fractures and to have used estrogen replacement therapy (see table 2 ). Users also tended to be more physically active. Turns antacid tablets and vitamin D users were more likely than were nonusers to have histories of fractures, osteoporosis, and estrogen use. We found a positive relation between the use of calcium and vitamin D supplements and a negative relation between the use of calcium supplements and Turns antacid tablets. Table 3 shows adjusted relative risks and 95 percent confidence intervals for the relation between dietary calcium intake and the risk of hip, ankle, proximal humeral, wrist, and vertebral fractures. None of the individual relative risks or tests for trend was statistically significant, but there was some suggestion of .0 (0.9-1.1)t  0.9(0.8-1.1)  0.9(0.7-1.1 .2(0.8-1.7)  0.8(0.4-1.3)  0.6 (0.3-1.3 .2(0.9-1.6)  1.2(0.8-1.8)  1.5(0.9-2 * Relative risks are adjusted for age, clinic, weight, history of osteoporosis, history of fractures since age 50, fall in past 12 months, protein intake (g/week), caffeine intake (see table 2), recreational physical activity (teal/week), take walks for exercise (yes/no), impaired low frequency contrast sensitivity, estrogen replacement therapy (current/not current), thiazide use (current/not current), and use of calcium supplements, vitamin D supplements, and Turns antacid tablets.
t Numbers in parentheses, 95% confidence interval.
reduced risk of ankle fractures with increased dietary calcium intake (test for trend p = 0.08). Also shown in Table 3 are adjusted relative risks for the association between current milk drinking and fractures. The findings for milk were essentially the same as for overall dietary calcium: no association with any type of fracture except ankle fractures. We also calculated relative risks for milk consumption at the ages of 12-18,19-50, and after the age of 50 years and during pregnancy and lactation (data not shown). We used the same categories of milk consumption as for current age. The only statistically significant finding was a protective association between drinking milk during pregnancy and lactation and the risk of first vertebral fracture among women with no vertebral fractures on baseline radiographs (test for trend p = 0.01).
Results for the use of calcium supplements, Turns antacid tablets, and vitamin D supplements are shown in table 4. Compared with never users, current users of calcium supplements were at increased risk of hip fractures (relative risk = 1.5) and vertebral fractures (relative risk = 1.4), and current users of Turns antacid tablets were at increased risk of proximal humeral fractures (relative risk = 1.7). Among current users, relative risks were similar for women who had used supplements for more than 10 years and women who had used them for shorter periods of time. Associations between the use of calcium supplements and fracture risk were the same in women with low and high dietary calcium intakes (data not shown).
Since vitamin D and calcium are both needed to maintain calcium balance, we calculated relative risks comparing current users of both vitamin D and calcium supplements (n = 3,365) with people who had never used either (n = 2,705). There was no evidence that a combination of calcium and vitamin D supplements protected against fractures; adjusted relative risks were 1.2 (any fracture), 1.4 (hip fractures), 0.7 (ankle fractures), 1.4 (proximal humeral fractures), 1.0 (wrist fractures), and 1.3 (vertebral fractures).
To minimize confounding by indications for use of supplements, we examined the relation between fractures and the current use of calcium supplements, Turns antacid tablets, and vitamin D supplements in women who had neither a history of previous fractures since age 50 nor a history of osteoporosis (n = 5,230). Calcium supplements were no longer associated with hip fractures among these women, but the associations between calcium supplements and vertebral fractures and between Turns antacid tablets and proximal humeral fractures persisted (see table 5 ). The use of vitamin D supplements was associated with an increased risk of hip fracture among these women without previous fractures or a history of osteoporosis.
Higher current daily intake of calcium from all sources (dietary calcium, calcium supplements, and Turns antacid tablets) was associated with increased * Relative risks are adjusted for age, clinic, weight, history of osteoporosis, history of fractures since age 50, fall in past 12 months, dietary calcium intake (mg/week), protein intake (g/week), caffeine intake (see table 2), recreational physical activity (kcal/week), take walks for exercise (yes/no), impaired low frequency contrast sensitivity, estrogen replacement therapy (current/not current), thiazide use (current/not current), and use of calcium supplements, vitamin D supplements, and Turns antacid tablets (where relevant).
risks of hip (test for trend p = 0.04), proximal humeral (test for trend p = 0.05), and vertebral (test for trend p < 0.001) fractures (data not shown). Adjusted relative risks comparing those in the top fifth (s 1,600 mg/day of calcium) with those in the bottom fifth (<400 mg/day of calcium) were 1.6 (hip fractures), 1.7 (proximal humeral fractures), and 2.5 (vertebral fractures). We examined the two subtypes of hip fracture (trochanteric and femoral neck fractures) separately (data not shown). There were no differences for dietary calcium and milk, but current use of calcium supplements appeared to be more strongly associated with trochanteric fractures than with femoral neck fractures. Among all subjects, adjusted relative risks comparing current with never users were 1.8 for trochanteric fractures and 1.3 for femoral neck fractures.
There were no meaningful interactions between calcium intake and physical activity, estrogen replacement therapy, or family history of fractures.
DISCUSSION
In this large cohort study, we found no associations between dietary calcium intake and the risk of several different types of fractures. Calcium supplements were associated with increased risk of some types of fracture.
Interpretation of our findings for calcium supplements is difficult, because these are now widely recommended for prevention and treatment of osteoporosis. It is probable that people at high risk of fractures are more likely to start taking calcium supplements than are people at lower risk. In our study, for example, supplement users were more likely than were nonusers to have a history of falls, fractures, or osteoporosis. We believe that this confounding by indication (36) is the most likely explanation for our finding of an increased risk of hip and vertebral fracture in users of calcium supplements and of proximal humeral fractures in Turns antacid tablets users. We cannot, however, exclude the possibility that supplements taken by our subjects had an adverse effect on fracture risk.
Other observational studies of calcium supplements have found increased risks of fractures (14) , no association (13, 37) , and reduced fracture risk (38) . The one study to find a protective effect was conducted among southern European women (38) , a population in which the type of women who use supplements, and * Relative risks are adjusted for age, clinic, weight, fall in past 12 months, dietary calcium intake (mg/week), protein intake (g/week), caffeine intake (see table 2), recreational physical activity (kcal/week), take walks for exercise (yes/no), impaired low frequency contrast sensitivity, estrogen replacement therapy (current/not current), thiazide use (current/not current), and use of calcium supplements, vitamin D supplements, and Turns antacid tablets (where relevant).
the indications for their use, may be very different from the participants in North American studies.
There have now been three small randomized trials of calcium supplements and radiographically defined, mostly asymptomatic, vertebral fractures (21-23). Recker et al. (21) found a statistically significant reduction in fracture rate among women taking calcium supplements. Chevalley et al. (22) also found a protective effect, but the statistical significance of this effect was dependent on the way that vertebral fractures were defined. Finally, although they found no difference in vertebral fracture rates, Reid et al. (23) reported fewer symptomatic fractures among women taking calcium (two fractures) than among those on placebo (nine fractures).
We found no evidence of a protective effect of vitamin D. A combination of vitamin D and calcium supplements has been shown to reduce the rate of fractures in nursing home residents (24) . However, the role of vitamin D supplements alone remains controversial. Ooms et al. (39) have shown that a small dose of vitamin D increases bone mass and, although unproven at present, vitamin D might also improve muscle strength and reduce falls (40) . In a randomized trial of people living in the community in the Netherlands, Lips et al. (41) found no effect of daily use of 400 International Units of vitamin D on the risk of hip fracture.
We found limited evidence of a protective effect of dietary calcium for fractures, consistent with most previous studies. Of 14 previous epidemiologic studies of dietary calcium and the risk of hip fractures (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , three found a statistically significant protective effect (9, 10, 18) . One of these studies, a case-control study from Hong Kong, was done among people with a very low mean calcium intake (less than 170 mg/day (10)). The one North American study to find a protective effect was the Rancho Bernardo cohort study, where there was a 40 percent reduction in hip fracture risk for each 300-mg increase in dietary calcium (9) . This was the one study to adjust for total caloric intake, using the nutrient density technique. This technique has several limitations (42) . The other study to find a protective effect was conducted among women living in southern European countries and involved only milk consumption (18) .
Two large US cohort studies have found no association between dietary calcium and hip fracture (13, 16) . Paganini-Hill et al. (13) followed 8,600 women for a mean of 5 years and found a relative risk for hip fracture of 1.1 (95 percent confidence interval 0.9-1.4) for women consuming more than 500 mg/day of calcium compared with those consuming less than 280 mg/day. Looker et al. (16) followed 2,226 women for a mean of 15 years and found a relative risk for hip fracture of 0.9 (95 percent confidence interval 0.5-1.6) for those consuming more than 1,000 mg/day of calcium compared with those consuming less than 400 mg/day. Case-control studies from the United States (15), the United Kingdom (7, 8, 11) , Canada (12, 14) , Scandinavia (19, 20) , and Australia (17) have also failed to find a protective effect of dietary calcium. Apart from an earlier report from the Study of Osteoporotic Fractures (43) , there has been one other study of dietary calcium and wrist fractures (14) . In a Canadian hospital-based case-control study, Kreiger et al. (14) found a statistically significant reduction in the risk of wrist fractures in women who consumed more than 1,000 mg/day of calcium. There have been no previous studies of dietary calcium and the risk of vertebral, ankle, or humeral fractures.
For assessment of dietary calcium and fractures, the Study of Osteoporotic Fractures has several strengths: prospective design, large numbers of fractures of many different types, good measurement of dietary calcium, and assessment of, and control for, a wide range of potential confounders. However, dietary calcium intake is difficult to assess accurately, and "noise" inherent in our measurement may have caused us to underestimate its true effect. Our study was done among women with a mean dietary calcium intake of 700 mg/day. Hence, our results do not rule out a large calcium effect in populations with much lower mean intakes.
Despite its large size, our study had limited power to detect small associations between dietary calcium intake and specific fracture types. For hip fractures, the study had 70 percent power to detect a relative risk of at least 0.7 for those with a calcium intake greater than 400 mg/day compared with those with lower intakes. Power was high for all fractures combined; the study had 90 percent power to detect a relative risk of at least 0.85 comparing these two groups of women.
Although the women in the Study of Osteoporotic Fractures were volunteers, this should not affect the generalizability of our findings for relations between risk factors and fractures. We also note that fracture incidence in our cohort is only slightly lower than in more representative populations. For example, in the age group in which hip fractures occur most frequently (80-84 years), hip fracture incidence in our study is 11.8 per 1,000 women per year, compared with 15.1 per 1,000 women per year in a population-based study in New England (44) .
In conclusion, we were unable to find a substantial beneficial effect of dietary calcium on fracture risk. Our data also confirm the difficulty of studying the effects of calcium supplements in observational studies. Randomized trials of calcium supplements with symptomatic fractures as the outcome are the best way to determine the efficacy of calcium for the prevention of fractures. A large trial of supplements of calcium together with vitamin D is currently underway in the United States, as part of the Women's Health Initiative that is sponsored by the National Institutes of Health.
